Ergoloid Mesylates

ANDA 87244, held by Watson Labs. Ergoloid Mesylates.

As of Nov 15, 2026, ANDA 87244 (Ergoloid Mesylates), held by Watson Labs, was first approved by FDA on Aug 16, 1982, with 12 approved supplements and 0 published complete response letters.

First approved: Aug 16, 1982
Supplements approved: 12
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 13 submissions below

Date	Submission	Status	Documents
Aug 16, 1982	Original application	Approved	None posted

Products

1 strengths and forms

Product	Active ingredient	Marketing
Ergoloid Mesylates1MG · tablet;oral	Ergoloid Mesylates	Discontinued

All 13 submissions, including labeling and manufacturing supplements


May 31, 1991	Supplement 13Manufacturing	Approved	None posted
Nov 19, 1990	Supplement 14Manufacturing	Approved	None posted
Jun 29, 1990	Supplement 12Manufacturing	Approved	None posted
Feb 7, 1989	Supplement 11Labeling	Approved	None posted
Dec 6, 1988	Supplement 7Labeling	Approved	None posted
Aug 5, 1988	Supplement 10Manufacturing	Approved	None posted
Aug 5, 1988	Supplement 9Manufacturing	Approved	None posted
Jul 20, 1988	Supplement 8Bioequivalence	Approved	None posted
Nov 27, 1985	Supplement 4Manufacturing	Approved	None posted
Nov 27, 1985	Supplement 3Manufacturing	Approved	None posted
Nov 27, 1985	Supplement 2Manufacturing	Approved	None posted
Sep 2, 1983	Supplement 1Manufacturing	Approved	None posted
Aug 16, 1982	Original application	Approved	None posted

Identifiers

Application: ANDA 87244
Drugs@FDA: Overview at FDA
Company: Watson Laboratories

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters